Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Pamufetinib mesylate | 1688673-09-7 | 99.2% | 614.66 g/mol | C28H27FN4O7S2 | 100MG
SDP

Supplier:  Medchemexpress LLC HY12423A100MG

Encompass_Preferred

Pamufetinib mesylate is an ATP-competitive, small-molecule inhibitor that targets vascular endothelial growth factor receptor (VEGFR) and hepatocyte growth factor receptor (c-Met/HGFR). Supplied as the mesylate salt for research use only, it exhibits potent in vitro kinase inhibition and is provided as a high-purity solid with recommended storage conditions to preserve stability.

  • Potent dual inhibition of VEGFR2 and MET (IC50 ≈ 30-32 nM).
  • High reported purity (99.2%).
  • Provided as a mesylate salt to improve handling and solubility for assays.
  • Available in a 100 mg pack size for research applications.
  • Solid, white to off-white appearance suitable for accurate weighing.
  • Storage recommendations: 4°C for powder; in solvent -80°C for long-term stability.

Catalog No. 50-002-36824


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.